1003313-84-5

Basic information

• Product Name: 1,1-dimethylethyl [2-({[4-(bromomethyl)phenyl]carbonyl}amino)-4-(2-thienyl)phenyl]carbamate
• Synonyms: 1,1-dimethylethyl [2-({[4-(bromomethyl)phenyl]carbonyl}amino)-4-(2-thienyl)phenyl]carbamate
• CAS NO: 1003313-84-5
• Molecular Weight: 487.417
• Mol File: 1003313-84-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1,1-dimethylethyl [2-({[4-(bromomethyl)phenyl]carbonyl}amino)-4-(2-thienyl)phenyl]carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: 1,1-dimethylethyl [2-({[4-(bromomethyl)phenyl]carbonyl}amino)-4-(2-thienyl)phenyl]carbamate(1003313-84-5)
• EPA Substance Registry System: 1,1-dimethylethyl [2-({[4-(bromomethyl)phenyl]carbonyl}amino)-4-(2-thienyl)phenyl]carbamate(1003313-84-5)

Safety Data

• Hazardous Substances Data: 1003313-84-5(Hazardous Substances Data)

Upstream product

• 335255-43-1 tert-butyl 2-amino-4-(thiophen-2-yl)phenylcarbamate 
• 876-07-3 4-(bromomethyl)benzoyl bromide 

Downstream Products

• 1003313-91-4 diethyl {2-[4-({[2-[(tert-butoxycarbonyl)amino]-5-(2-thienyl)phenyl]amino}carbonyl)phenyl]-1-cyanoethyl}phosphonate 
• 1003314-26-8 methyl [4-({[2-[(tert-butoxycarbonyl)amino]-5-(2-thienyl)phenyl]amino}carbonyl)benzyl]methyl-phosphinate 
• 1003315-12-5 C₂₉H₃₇N₂O₄PS 
• 1003314-25-7 [4-(2-tert-butoxycarbonylamino-5-thiophen-2-yl-phenylcarbamoyl)benzyl]-methyl-phosphinic acid ethyl ester 
• 1003316-26-4 diethyl [({[4-({[2-({[(1,1-dimethylethyl)oxy]carbonyl}amino)-5-(2-thienyl)phenyl]amino}carbonyl)phenyl]methyl}amino)methyl]phosphonate 

Relevant articles and documents

SILICON DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS

The present invention relates to a novel class of Silicon derivatives. The Silicon compounds can be used to treat cancer. The Silicon compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation,

PHOSPHORUS DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS

The present invention relates to a novel class of phosphorus derivatives. The phosphorus compounds can be used to treat cancer. The phosphorus compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing terminal differe